Clark, J. I., Wong, M. K., Kaufman, H. L., Daniels, G. A., Morse, M. A., McDermott, D. F., . . . Aung, S. (2016). Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM(SM). Clin Genitourin Cancer.
Styl ChicagoClark, Joseph I., et al. "Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM(SM)." Clin Genitourin Cancer 2016.
Citace podle MLAClark, Joseph I., et al. "Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM(SM)." Clin Genitourin Cancer 2016.